This Trial closed to accrual on March 29th 2002.
Two-hundred and ninety nine patients have been accessioned
to this trial nationally. One patient has been entered from
Johns Hopkins (entered the trial on 03/07/1997). The patient
was randomized to Arm I (I-PCV x 4 cycles followed by XRT).
He completed the study therapy in 1997. The patient who enrolled
on this trial at Hopkins has not experienced any adverse event
related to the study treatment. Patient has been in Follow-up
since 1998.
|